Inventiva S.A. (EPA:IVA)
France · Delayed Price · Currency is EUR 5.59
+0.22 (4.10%)
Feb 19, 2026, 5:35 PM CET
Inventiva Market Cap
Inventiva has a market cap or net worth of €1.03 billion as of February 19, 2026. Its market cap has increased by 373.45% in one year.
Market Cap
1.03B
Enterprise Value
1.04B
Revenue
16.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.59
Market Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 1.03B, an increase of 662.45%. That is a compound annual growth rate of 25.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 1.03B | 36.12% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.11B |
| DBV Technologies | 1.04B |
| Valneva SE | 804.13M |
| MedinCell | 793.15M |
| Genfit | 391.64M |
| Cellectis | 252.42M |
| Transgene | 231.11M |
| MaaT Pharma | 142.25M |